Kentucky legislation · 2026 Regular Session
Kentucky HB388: AN ACT relating to prescription drugs.
Status: Signed into law, April 7, 2026
Amend KRS 205.529, 218A.172, 218A.205, and 304.17A.165 to remove references to a Schedule III controlled substance containing hydrocodone; amend KRS 218A.010 to add optometrist and physician assistant to the definition of "practitioner" licensed in other states; amend KRS 218A.182 to exempt charitable health care practitioners from electronic prescription requirement; amend KRS 218A.202 to require an active account with the electronic monitoring system be maintained by practitioners or pharmacists prescribing or dispensing Schedule II, III, IV, or V controlled substances; amend KRS 218A.245 to permit the Cabinet for Health and Family Services to enter reciprocal agreements or contracts with any federal agency of the United States or its territories.
What the bill says
An act relating to prescription drugs.
From the introduced text:
AN ACT relating to prescription drugs. Be it enacted by the General Assembly of the Commonwealth of Kentucky: Section 1. KRS 205.529 is amended to read as follows: (1) The Department for Medicaid Services or a managed care organization contracted to provide services pursuant to this chapter shall provide a program for synchronization of medications when it is agreed among the member, a provider, and a pharmacist that synchronization of multiple prescriptions for the treatment of a chronic illness is in the best interest of the patient for the management or treatment of a chronic illness provided that the medications: (a) Are covered by the Department for Medicaid Services or a managed care organization contracted to provide services pursuant to this chapter; (b) Are used for treatment and management of chronic conditions that are subject to refills; (c) Are not a Schedule II controlled substance[ or a Schedule III controlled substance containing hydrocodone]; (d) Meet all prior authorization criteria specific to the medications at the time of the synchronization request; (e) Are of a formulation that can be effectively split over required short fill periods to achieve synchronization; and (f) Do not have quantity limits or dose optimization criteria or requirements that would be violated in fulfilling synchronization. (2) When applicable to permit synchronization, the Department for Medicaid Services or …
Sponsors
- Robert Duvall (R, HD-017) · primary sponsor
- Kimberly Moser (R, HD-064)
Latest actions
- : signed by Governor (Acts Ch. 38)
- : delivered to Governor
- : enrolled, signed by President of the Senate
- : enrolled, signed by Speaker of the House
- : received in House
- : 3rd reading, passed 38-0
- : passed over and retained in the Consent Orders of the Day
- : posted for passage in the Consent Orders of the Day for Tuesday, March 24 2026
- : 2nd reading, to Rules as a consent bill
- : reported favorably, 1st reading, to Consent Calendar
Votes
- Senate: Floor Vote RSN# 4002 (March 25, 2026): 38 yea, 0 nay, passed
- House: Pass RCS# 66 (February 6, 2026): 92 yea, 0 nay, passed
Subjects: State Agencies, Health Care Professionals, Physicians, Drugs And Medicines, Pharmacists, Health And Medical Services, Optometrists
Common questions
- What is HB388?
- HB388 is a bill in the Kentucky Legislature (2026 Regular Session): AN ACT relating to prescription drugs.
- What does HB388 do?
- In its own words: An act relating to prescription drugs.
- What is the status of HB388?
- Signed into law as of April 7, 2026. Latest action: signed by Governor (Acts Ch. 38) (April 7, 2026).
- Who sponsored HB388?
- Robert Duvall (R, HD-017), with 1 co-sponsor.
- Where is the official record for HB388?
- On the Kentucky Legislature website: https://apps.legislature.ky.gov/record/26rs/hb388.html
Source: official Kentucky record. Tracked by Delilah, AI for legislation across all 50 states and Congress.